Endpoints News· @endpts · X·· 19 天前AI 评分52
AI 导读
Dren Bio 完成 3.5 亿美元融资,用于推动其血液肿瘤主导药物在 2027 年底前上市。Endpoints News 报道了这一独家消息,但未披露具体药物名称与投资方信息。
正文
Exclusive: Dren Bio raised $350M to get its lead blood cancer drug onto the market by the end of 2027. https://endpoints.news/dren-bio-raises-350m-to-get-blood-cancer-drug-onto-market-in-2027/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial
来源:Endpoints News · x.com